US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Direxion Daily S&P Biotech Bull 3x Shares

218.48

-9.2700-4.07%

Volume:89.89K

Turnover:19.71M

Market Cap:551.55M

PE:- -

High:223.71

Open:220.01

Low:215.48

Close:227.75

52wk High:341.93

52wk Low:102.35

Shares:2.52M

Float Shares:2.52M

Volume Ratio:5.54

T/O Rate:3.56%

Dividend:0.91

Dividend Rate:0.42%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Vir Biotechnology gains FDA Fast Track for VIR-5500

Analysts’ Top Healthcare Picks: Gilead Sciences (GILD), Rhythm Pharmaceuticals (RYTM)

Beyond Air® Preannounces Preliminary Revenue for the Quarter Ended September 30, 2026

Press Release: Diversified Healthcare Trust Announces Quarterly Dividend on Common Shares

Kingdomway's Subsidiary Receives FDA GRAS No Objection Letter for Brazzein Sweet Protein Product

Perspective's Cancer Therapy Candidate Receives FDA Fast Track Designation; Shares Rise Pre-Bell

MT Newswires Live

EPF lifts stake in IHH Healthcare to 13.3% via fresh share acquisitions

Perspective Therapeutics Wins FDA Fast Track for PSV359

Analysts Offer Insights on Healthcare Companies: Mirum Pharmaceuticals (MIRM), Connect Biopharma Holdings (CNTB) and Helus Pharma (HELP)

Humanwell Healthcare's Subsidiary Secures FDA Approval for Diltiazem Hydrochloride Tablets

Analysts Offer Insights on Healthcare Companies: Rocket Pharmaceuticals (RCKT) and Chemed (CHE)

Analysts Conflicted on These Healthcare Names: Johnson & Johnson (JNJ) and NeoGenomics (NEO)

Health Care Roundup: Market Talk

Daiichi-Linked Investors Exit Substantial Holding in Ramsay Health Care

Analysts Offer Insights on Healthcare Companies: CSL (OtherCMXHF) and Demant (OtherWILLF)

Allist Pharmaceuticals Hits 20cm Limit Down, Market Cap Plummets Over 10 Billion Yuan in One Day; Zhongou Healthcare Mixed A Faces Nearly 20 Million Yuan Paper Loss

Newron presses on with Evenamide Phase 3 as FDA halts U.S. arm over safety signal

Newron presses on with ENIGMA-TRS program as FDA clinical hold prompts safety review

Noxopharm Says US FDA Feedback Supports Planned Phase II Trial Approach for Autoimmune Drug Candidate

MT Newswires Live

Top Executive Makes Major Move With Alignment Healthcare Stock

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/LABU/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"LABU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","market":"US","secType":"STK","nameCN":"Direxion Daily S&P Biotech Bull 3x Shares","latestPrice":218.48,"timestamp":1791466897960,"preClose":227.75,"halted":0,"volume":89885,"delay":0,"changeRate":-0.040702524698133964,"floatShares":2524486,"shares":2524486,"eps":0,"marketStatus":"Trading","change":-9.27,"latestTime":"10-08 09:41:38 EDT","open":220.01,"high":223.7074,"low":215.475,"amount":19713433.48515,"amplitude":0.036147,"askPrice":219.13,"askSize":10,"bidPrice":218,"bidSize":510,"shortable":3,"etf":3,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1791489600000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":227.75,"sharesOutstanding":3074486,"nav":230.529,"aum":581967299.18,"dividendRate":0.00417,"bidAskSpread":0.002401,"preHourTrading":{"tag":"盘前","latestPrice":220.18,"preClose":227.75,"latestTime":"09:29 EDT","volume":6169,"amount":1385605.45651,"timestamp":1791466199999,"change":-7.57,"changeRate":-0.033238,"amplitude":0.038727},"postHourTrading":{"tag":"盘后","latestPrice":228.7,"preClose":227.75,"latestTime":"19:59 EDT","volume":2729,"amount":623483.6155,"timestamp":1791417573520,"change":0.95,"changeRate":0.004171,"amplitude":0.004911},"volumeRatio":5.538552,"impliedVol":0.9716,"impliedVolPercentile":0.7211},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","floatShares":2524486,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":5.538552,"shares":2524486,"dividePrice":0.911,"high":223.7074,"amplitude":0.036147,"preClose":227.75,"low":215.475,"week52Low":102.3547,"pbRate":"--","week52High":341.93,"institutionHeld":0,"latestPrice":218.48,"committee":0.961538,"eps":0,"divideRate":0.00417,"volume":89885,"delay":0,"ttmEps":0,"open":220.01,"prevYearClose":159.39,"prevWeekClose":248.72,"prevMonthClose":265.79,"prevQuarterClose":265.79,"fiveDayClose":249.65,"twentyDayClose":266,"sixtyDayClose":277.55},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LABU\",params:#limit:5,,,undefined,":[{"date":"2025-09-23","symbol":"LABU","amount":0.10273,"announcedDate":"2025-09-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-23","defaultRemindTime":1758634200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-30","payableDate":"2025-09-23","currency":"USD","dateTimestamp":1758600000000,"payDate":"2025-09-30"},{"date":"2025-06-24","symbol":"LABU","amount":0.21897,"announcedDate":"2025-06-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-24","defaultRemindTime":1750771800000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-01","payableDate":"2025-06-24","currency":"USD","dateTimestamp":1750737600000,"payDate":"2025-07-01"},{"date":"2025-03-25","symbol":"LABU","amount":0.10714,"announcedDate":"2025-03-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-25","defaultRemindTime":1742909400000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-01","payableDate":"2025-03-25","currency":"USD","dateTimestamp":1742875200000,"payDate":"2025-04-01"},{"date":"2024-06-25","symbol":"LABU","amount":0.15021,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-25","defaultRemindTime":1719322200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-07-02","payableDate":"2024-06-25","currency":"USD","dateTimestamp":1719288000000,"payDate":"2024-07-02"},{"date":"2024-03-19","symbol":"LABU","amount":0.16064,"announcedDate":"2024-03-18","type":"dividend","market":"US","newRecordDate":"2024-03-20","defaultRemindTime":1710855000000,"name":"三倍做多标普生物-Direxion","recordDate":"2024-03-26","payableDate":"2024-03-20","currency":"USD","dateTimestamp":1710820800000,"payDate":"2024-03-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LABU\",market:\"US\",,,undefined,":[{"executeDate":"2018-06-19","recordDate":"2018-06-20","paymentDate":"2018-06-26","value":0.01932,"currency":"USD"},{"executeDate":"2018-09-25","recordDate":"2018-09-26","paymentDate":"2018-10-02","value":0.0954,"currency":"USD"},{"executeDate":"2018-12-27","recordDate":"2018-12-28","paymentDate":"2019-01-04","value":0.09621,"currency":"USD"},{"executeDate":"2019-03-19","recordDate":"2019-03-20","paymentDate":"2019-03-26","value":0.10973,"currency":"USD"},{"executeDate":"2019-06-25","recordDate":"2019-06-26","paymentDate":"2019-07-02","value":0.03745,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LABU\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LABU\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2673077045","title":"Vir Biotechnology gains FDA Fast Track for VIR-5500","url":"https://stock-news.laohu8.com/highlight/detail?id=2673077045","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673077045?lang=en_us&edition=fundamental","pubTime":"2026-10-08 20:58","pubTimestamp":1791464310,"startTime":"0","endTime":"0","summary":"Vir Biotechnology ( ($VIR) ) has shared an announcement. On October 6, 2026, Vir Biotechnology announced that the U.S. Food and Drug Administration...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/vir-biotechnology-gains-fda-fast-track-for-vir-5500?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/vir-biotechnology-gains-fda-fast-track-for-vir-5500?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["VIR","LABU","BK4535","BK4568","BK4585","BK4139","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673133072","title":"Analysts’ Top Healthcare Picks: Gilead Sciences (GILD), Rhythm Pharmaceuticals (RYTM)","url":"https://stock-news.laohu8.com/highlight/detail?id=2673133072","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673133072?lang=en_us&edition=fundamental","pubTime":"2026-10-08 20:10","pubTimestamp":1791461430,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Gilead Sciences (GILD) and Rhythm Pharmaceuticals (R...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-gilead-sciences-gild-rhythm-pharmaceuticals-rytm-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-gilead-sciences-gild-rhythm-pharmaceuticals-rytm-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GILD","IBB","LU0234570918.USD","LU0965508806.USD","BK4585","LU0882574055.USD","LU0965509010.AUD","LU1674673428.USD","IE00B3T34201.USD","LU1934455277.USD","LU2357627491.SGD","TMED","BK4583","IE00BZ1G4Q59.USD","LU1934455863.HKD","XBI","LU2324357040.USD","TBXU","LU2468319806.SGD","IE00B19Z3581.USD","BK4137","LU0058720904.USD","LU1023059063.AUD","LU2112291526.USD","LU2089984988.USD","IE00B7SZLL34.SGD","BIB","IE0002270589.USD","BK4568","LABU","SG9999015986.USD","BK4566","LU0029874061.USD","LU0965509283.SGD","LU1066053197.SGD","SG9999015978.USD","LU0965509101.SGD","MEDI","LU1037948897.HKD","LU0823416689.USD","XLV","IE00B19Z3B42.SGD","BBH","BK4532","LU0320765992.SGD","HCSG","RYTM","IBBQ","BMED","LU1934455194.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673072619","title":"Beyond Air® Preannounces Preliminary Revenue for the Quarter Ended September 30, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2673072619","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673072619?lang=en_us&edition=fundamental","pubTime":"2026-10-08 20:00","pubTimestamp":1791460800,"startTime":"0","endTime":"0","summary":"Preliminary revenue of $2.3 million represents the highest quarterly revenue reported, and approximately 30% sequential quarterly growth and 27% growth over the same period last year Performance refle","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/10/08/3377217/0/en/beyond-air-preannounces-preliminary-revenue-for-the-quarter-ended-september-30-2026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XAIR","LABU","BK4585","BK4082","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673007412","title":"Press Release: Diversified Healthcare Trust Announces Quarterly Dividend on Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2673007412","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673007412?lang=en_us&edition=fundamental","pubTime":"2026-10-08 20:00","pubTimestamp":1791460800,"startTime":"0","endTime":"0","summary":"NEWTON, Mass.--(BUSINESS WIRE)--October 08, 2026--Diversified Healthcare Trust (Nasdaq: DHC) today announced a regular quarterly cash distribution on its common shares of $0.01 per share ($0.04 per sh","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","DHC","BK4203","BK4581","BK4225","XBI","BK4588","HAUS","XLV","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1114859472","title":"Kingdomway's Subsidiary Receives FDA GRAS No Objection Letter for Brazzein Sweet Protein Product","url":"https://stock-news.laohu8.com/highlight/detail?id=1114859472","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1114859472?lang=en_us&edition=fundamental","pubTime":"2026-10-08 18:58","pubTimestamp":1791457108,"startTime":"0","endTime":"0","summary":"Xiamen Kingdomway Group Company (002626.SZ) has announced that its wholly-owned subsidiary, Inner Mongolia Kingdomway Pharmaceutical Co., Ltd. (\"Kingdomway Pharmaceutical\"), recently received a no...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["002626","BK0197","BK4585","BK0077","159100","BK4588","BK0226","BK0191","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673407600","title":"Perspective's Cancer Therapy Candidate Receives FDA Fast Track Designation; Shares Rise Pre-Bell","url":"https://stock-news.laohu8.com/highlight/detail?id=2673407600","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673407600?lang=en_us&edition=fundamental","pubTime":"2026-10-08 18:53","pubTimestamp":1791456799,"startTime":"0","endTime":"0","summary":"Perspective Therapeutics  said Thursday that the US Food and Drug Administration, or FDA, granted fast track designation for the development of PSV359, an experimental cancer treatment for adults with advanced tumors that cannot be removed through surgery or have spread to other parts of the body.The investigational therapy is being studied in an ongoing Phase 1/2a trial in patients with advanced fibroblast activation protein-positive solid tumors, the company said.The company said early human imaging data showed strong tumor uptake and rapid kidney clearance for PSV359.The FDA's fast track program is aimed at accelerating the development and review of therapies for serious conditions with unmet medical needs, the company added.Shares rose around 4.9% in premarket trading.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LABU","BK4139","BK4585","CATX","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673079644","title":"EPF lifts stake in IHH Healthcare to 13.3% via fresh share acquisitions","url":"https://stock-news.laohu8.com/highlight/detail?id=2673079644","media":"TIPRANKS","labels":["shareholding","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673079644?lang=en_us&edition=fundamental","pubTime":"2026-10-08 18:51","pubTimestamp":1791456679,"startTime":"0","endTime":"0","summary":"IHH Healthcare Bhd ( ($IHHHF) ) has provided an announcement. Malaysia’s Employees Provident Fund Board has increased its direct stake in IHH Healt...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/epf-lifts-stake-in-ihh-healthcare-to-13-3-via-fresh-share-acquisitions?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/epf-lifts-stake-in-ihh-healthcare-to-13-3-via-fresh-share-acquisitions?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,merge","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4137","BK4581","BK4585","BK4588","XLV","LABU","LU0029874061.USD","XBI","LU0128526141.USD","HCSG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673079980","title":"Perspective Therapeutics Wins FDA Fast Track for PSV359","url":"https://stock-news.laohu8.com/highlight/detail?id=2673079980","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673079980?lang=en_us&edition=fundamental","pubTime":"2026-10-08 18:48","pubTimestamp":1791456486,"startTime":"0","endTime":"0","summary":"Perspective Therapeutics ( ($CATX) ) has issued an update. On October 8, 2026, Perspective Therapeutics announced that the U.S. Food and Drug Admin...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/perspective-therapeutics-wins-fda-fast-track-for-psv359?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/perspective-therapeutics-wins-fda-fast-track-for-psv359?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4588","LABU","CATX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673076180","title":"Analysts Offer Insights on Healthcare Companies: Mirum Pharmaceuticals (MIRM), Connect Biopharma Holdings (CNTB) and Helus Pharma (HELP)","url":"https://stock-news.laohu8.com/highlight/detail?id=2673076180","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673076180?lang=en_us&edition=fundamental","pubTime":"2026-10-08 18:30","pubTimestamp":1791455457,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Mirum Pharmaceuticals (MIRM), Connect Biopharma Hold...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-mirum-pharmaceuticals-mirm-connect-biopharma-holdings-cntb-and-helus-pharma-help-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-mirum-pharmaceuticals-mirm-connect-biopharma-holdings-cntb-and-helus-pharma-help-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","XLV","BK4137","XBI","LABU","MIRM","BK4139","LU0029874061.USD","CNTB","BK4007","HCSG","BK4585","LU0128526141.USD","HELP","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1125924715","title":"Humanwell Healthcare's Subsidiary Secures FDA Approval for Diltiazem Hydrochloride Tablets","url":"https://stock-news.laohu8.com/highlight/detail?id=1125924715","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1125924715?lang=en_us&edition=fundamental","pubTime":"2026-10-08 17:38","pubTimestamp":1791452288,"startTime":"0","endTime":"0","summary":"Humanwell Healthcare (Group) Co., Ltd. (ASX: 600079.SH) announced that its controlling subsidiary, Yichang Humanwell Pharmaceutical Co., Ltd. (Yichang Humanwell), has received approval from the U.S....","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","600079","BK0070","BK0028","BK0012","BK4585","LABU","BK0096","BK0239","BK0185","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673207450","title":"Analysts Offer Insights on Healthcare Companies: Rocket Pharmaceuticals (RCKT) and Chemed (CHE)","url":"https://stock-news.laohu8.com/highlight/detail?id=2673207450","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673207450?lang=en_us&edition=fundamental","pubTime":"2026-10-08 17:10","pubTimestamp":1791450618,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Rocket Pharmaceuticals (RCKT) and Chemed (CHE). Ro...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-rocket-pharmaceuticals-rckt-and-chemed-che-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-rocket-pharmaceuticals-rckt-and-chemed-che-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1165135440.EUR","LU0029874061.USD","LU1543694498.USD","XBI","LU2413665964.HKD","IE00B64QTZ34.USD","BK4137","LU1721427968.SGD","IE00BLDYK493.USD","LU1620156213.USD","RCKT","LU0128526141.USD","BK4581","BK4139","CHE","BK4196","LABU","LU1620156130.USD","XLV","BK4585","LU1596574779.USD","LU2413666004.HKD","HCSG","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673776027","title":"Analysts Conflicted on These Healthcare Names: Johnson & Johnson (JNJ) and NeoGenomics (NEO)","url":"https://stock-news.laohu8.com/highlight/detail?id=2673776027","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673776027?lang=en_us&edition=fundamental","pubTime":"2026-10-08 16:40","pubTimestamp":1791448815,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Johnson & Johnson (JNJ) and NeoGenomics (NEO). Johnson & Johnson ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-johnson-johnson-jnj-and-neogenomics-neo-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-johnson-johnson-jnj-and-neogenomics-neo-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0234570918.USD","BMED","LU2592432038.USD","LU2750360641.GBP","LU1261432733.SGD","LU1066053197.SGD","HCSG","IHE","LU1032466523.USD","LU0426412945.USD","MEDX","GDOC","LU0640476718.USD","LU0795875169.SGD","XLV","LU1057294990.SGD","LU1718418525.SGD","JNJ","IXJ","JDOC","XBI","LU2756315664.SGD","RXL","LU1929549753.HKD","VHT","IE00B4R5TH58.HKD","NEO","LU1059921491.USD","IE00B3PB1722.GBP","IE00B19Z3581.USD","PJP","IE000M9KFDE8.USD","IE0002270589.USD","BK4592","LU1674673691.USD","IE00BFTCPJ56.SGD","LABU","FHLC","LU0098860793.USD","LU1551013342.USD","FBT","IYH","LU0432979614.USD","LU1228905037.USD","LU2505996681.GBP","FTXH","TRUH","LU1145028129.USD","LU0545039389.USD","LU0345769631.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673225620","title":"Health Care Roundup: Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2673225620","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673225620?lang=en_us&edition=fundamental","pubTime":"2026-10-08 16:20","pubTimestamp":1791447600,"startTime":"0","endTime":"0","summary":"The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET.0707 GMT - Fresenius Medical Care's surprise CEO change will be ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LABU","BK4588","BK4585","XLV","BK4581","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673021086","title":"Daiichi-Linked Investors Exit Substantial Holding in Ramsay Health Care","url":"https://stock-news.laohu8.com/highlight/detail?id=2673021086","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673021086?lang=en_us&edition=fundamental","pubTime":"2026-10-08 15:37","pubTimestamp":1791445038,"startTime":"0","endTime":"0","summary":"Ramsay Health Care ( ($AU:RHC) ) has shared an update. Ramsay Health Care has disclosed that TAL Daiichi Life Australia and its related Daiichi Lif...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/daiichi-linked-investors-exit-substantial-holding-in-ramsay-health-care?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/daiichi-linked-investors-exit-substantial-holding-in-ramsay-health-care?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4510","BK4211","LABU","IE00B0JY6N72.USD","BK4581","BK4204","BK4531","ISBC","BK4548","XBI","LU1880383440.USD","TAL","BK4588","LU1880383366.USD","BK4526","BK4535","BK4506","BK4585","BK4503","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673260900","title":"Analysts Offer Insights on Healthcare Companies: CSL (OtherCMXHF) and Demant (OtherWILLF)","url":"https://stock-news.laohu8.com/highlight/detail?id=2673260900","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673260900?lang=en_us&edition=fundamental","pubTime":"2026-10-08 14:50","pubTimestamp":1791442209,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on CSL (CMXHF) and Demant (WILLF). CSL (CMXHF) In a r...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-csl-othercmxhf-and-demant-otherwillf-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-csl-othercmxhf-and-demant-otherwillf-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","BK4588","LU0029874061.USD","HCSG","BK4139","BK4585","BK4137","XLV","BK4082","BK4581","CMXHF","XBI","WILLF","LU0128526141.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1138310246","title":"Allist Pharmaceuticals Hits 20cm Limit Down, Market Cap Plummets Over 10 Billion Yuan in One Day; Zhongou Healthcare Mixed A Faces Nearly 20 Million Yuan Paper Loss","url":"https://stock-news.laohu8.com/highlight/detail?id=1138310246","media":"Deep News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1138310246?lang=en_us&edition=fundamental","pubTime":"2026-10-08 14:00","pubTimestamp":1791439238,"startTime":"0","endTime":"0","summary":"On the first trading day after the 2026 National Day holiday, Shanghai Allist Pharmaceuticals Co.,Ltd. (688578.SH) hit the daily limit down on a one-word board due to the global Phase III clinical...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0239","BK4581","BK4585","BK4588","IXJ","XLV","159760","BK4550","VHT","LABU","XBI","688578"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673023380","title":"Newron presses on with Evenamide Phase 3 as FDA halts U.S. arm over safety signal","url":"https://stock-news.laohu8.com/highlight/detail?id=2673023380","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673023380?lang=en_us&edition=fundamental","pubTime":"2026-10-08 13:34","pubTimestamp":1791437660,"startTime":"0","endTime":"0","summary":"Newron Pharmaceuticals SpA ( ($CH:NWRN) ) has shared an announcement. Newron Pharmaceuticals said the U.S. FDA has issued a clinical hold on U.S. t...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/newron-presses-on-with-evenamide-phase-3-as-fda-halts-u-s-arm-over-safety-signal?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/newron-presses-on-with-evenamide-phase-3-as-fda-halts-u-s-arm-over-safety-signal?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SYNB","BK4585","LABU","BK4588","IBB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673023384","title":"Newron presses on with ENIGMA-TRS program as FDA clinical hold prompts safety review","url":"https://stock-news.laohu8.com/highlight/detail?id=2673023384","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673023384?lang=en_us&edition=fundamental","pubTime":"2026-10-08 13:32","pubTimestamp":1791437568,"startTime":"0","endTime":"0","summary":"An announcement from Newron Pharmaceuticals SpA ( ($CH:NWRN) ) is now available. Newron Pharmaceuticals has received a formal notification from the...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/newron-presses-on-with-enigma-trs-program-as-fda-clinical-hold-prompts-safety-review?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/newron-presses-on-with-enigma-trs-program-as-fda-clinical-hold-prompts-safety-review?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","IBBQ","PSCH","PILL","LABU","BBC","PTH","BK4585","BIS","IBB","MEDX","SYNB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673044724","title":"Noxopharm Says US FDA Feedback Supports Planned Phase II Trial Approach for Autoimmune Drug Candidate","url":"https://stock-news.laohu8.com/highlight/detail?id=2673044724","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673044724?lang=en_us&edition=fundamental","pubTime":"2026-10-08 10:24","pubTimestamp":1791426258,"startTime":"0","endTime":"0","summary":"Noxopharm   said the US Food and Drug Administration has provided constructive feedback that was supportive of its planned approach for a phase II clinical trial for SOF-SKN, its autoimmune disease drug candidate, according to a Thursday Australian bourse filing.The company said the feedback provides increased regulatory clarity, and helps de-risk the drug candidate's development pathway, while it will incorporate the feedback into preparations for a future investigational new drug  submission that has the potential to increase SOF-SKN's commercial attractiveness.The phase II trial is targeted for the first half of calendar 2028, subject to regulatory, clinical and manufacturing requirements, it said.The company said an orphan drug designation opportunity exists for SOF-SKN, given there are no current targeted therapies.The company's shares fell nearly 2% in recent Thursday trade.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IND.AU","IND","BK4585","LABU","BK7095","BK7067","BK7501","BK4588","NOX.AU","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673044473","title":"Top Executive Makes Major Move With Alignment Healthcare Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2673044473","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673044473?lang=en_us&edition=fundamental","pubTime":"2026-10-08 10:02","pubTimestamp":1791424972,"startTime":"0","endTime":"0","summary":"New insider activity at Alignment Healthcare ( ($ALHC) ) has taken place on October 7, 2026. Alignment Healthcare’s Chief Medical Officer, Hyong Ki...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/insider-trading/top-executive-makes-major-move-with-alignment-healthcare-stock-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/insider-trading/top-executive-makes-major-move-with-alignment-healthcare-stock-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XLV","BK4539","BK4588","BK4585","LABU","ALHC","BK4154","BK4581","XBI"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":21,"pageCount":1,"totalSize":418,"code":"91000000","status":"200"}]}}